Jo Stevens

462 total citations
15 papers, 295 citations indexed

About

Jo Stevens is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Jo Stevens has authored 15 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Jo Stevens's work include Myasthenia Gravis and Thymoma (5 papers), Peripheral Neuropathies and Disorders (5 papers) and Autoimmune Neurological Disorders and Treatments (4 papers). Jo Stevens is often cited by papers focused on Myasthenia Gravis and Thymoma (5 papers), Peripheral Neuropathies and Disorders (5 papers) and Autoimmune Neurological Disorders and Treatments (4 papers). Jo Stevens collaborates with scholars based in Netherlands, Belgium and Spain. Jo Stevens's co-authors include Pilar Martínez‐Martínez, Mario Losen, Peter Molenaar, Socrates J. Tzartos, Konstantinos Lazaridis, Marc H. De Baets, Abhishek Saxena, Inga Koneczny, Angela Vincent and Anna De Rosa and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Jo Stevens

14 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Stevens Netherlands 10 151 50 48 34 25 15 295
F. Norwood United Kingdom 7 193 1.3× 25 0.5× 60 1.3× 19 0.6× 10 0.4× 9 314
Yashasvee Munshi United States 8 77 0.5× 91 1.8× 85 1.8× 7 0.2× 43 1.7× 10 360
Eva Eliassen United States 7 111 0.7× 55 1.1× 27 0.6× 15 0.4× 78 3.1× 9 319
Sophie Lehnerer Germany 10 200 1.3× 58 1.2× 44 0.9× 11 0.3× 34 1.4× 29 321
Paola Vázquez-Cárdenas Mexico 8 67 0.4× 44 0.9× 110 2.3× 9 0.3× 35 1.4× 12 332
Tingbao Zhang China 9 111 0.7× 41 0.8× 28 0.6× 3 0.1× 45 1.8× 41 249
Simon A. Balogun Nigeria 5 109 0.7× 117 2.3× 22 0.5× 4 0.1× 23 0.9× 20 268
Stephanie Chong United States 8 42 0.3× 38 0.8× 197 4.1× 22 0.6× 37 1.5× 12 445
Marc Waase United States 13 62 0.4× 59 1.2× 68 1.4× 6 0.2× 13 0.5× 16 292

Countries citing papers authored by Jo Stevens

Since Specialization
Citations

This map shows the geographic impact of Jo Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Stevens more than expected).

Fields of papers citing papers by Jo Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Stevens. The network helps show where Jo Stevens may publish in the future.

Co-authorship network of co-authors of Jo Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Stevens. A scholar is included among the top collaborators of Jo Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Stevens. Jo Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mané-Damas, Marina, Abhishek Saxena, Gisela Nogales‐Gadea, et al.. (2025). Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients. Frontiers in Immunology. 16. 1521432–1521432. 1 indexed citations
2.
Mudiyanselage, Shalika Bohingamu, et al.. (2023). Cost-effectiveness of personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial. PLoS ONE. 18(6). e0286533–e0286533. 10 indexed citations
3.
Mané-Damas, Marina, Jo Stevens, Kishore S. Malyavantham, et al.. (2021). The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens. Schizophrenia Research. 228. 462–471. 8 indexed citations
4.
Hoedt, Sandra den, Simone M. Crivelli, Frank Leijten, et al.. (2021). Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice. Frontiers in Aging Neuroscience. 13. 765252–765252. 14 indexed citations
5.
Crivelli, Simone M., Qian Luo, Jo Stevens, et al.. (2020). Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer’s disease transgenic mice by functioning as a metabolic probe. Scientific Reports. 10(1). 19354–19354. 14 indexed citations
6.
Stevens, Jo, Abhishek Saxena, Cem İ̇smail Küçükali, et al.. (2018). Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder. PLoS ONE. 13(12). e0208412–e0208412. 7 indexed citations
7.
Verheijen, Bert M., Jo Stevens, Daniël van den Hove, et al.. (2018). Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model. Neurobiology of Aging. 72. 62–71. 9 indexed citations
8.
Mudiyanselage, Shalika Bohingamu, Jo Stevens, Jennifer J Watts, et al.. (2018). Personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial. Journal of Telemedicine and Telecare. 25(6). 343–352. 46 indexed citations
9.
Saxena, Abhishek, Jo Stevens, Hakan Çetin, et al.. (2017). Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient. Scientific Reports. 7(1). 14426–14426. 15 indexed citations
10.
Gomez, Alejandro M., Jo Stevens, Marina Mané-Damas, et al.. (2016). Silencing of Dok-7 in Adult Rat Muscle Increases Susceptibility to Passive Transfer Myasthenia Gravis. American Journal Of Pathology. 186(10). 2559–2568. 11 indexed citations
11.
Koneczny, Inga, Jo Stevens, Anna De Rosa, et al.. (2016). IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. Journal of Autoimmunity. 77. 104–115. 93 indexed citations
12.
Martínez‐Martínez, Pilar, Peter Molenaar, Jo Stevens, et al.. (2015). [Auto-immune disorders as a possible cause of neuropsychiatric syndromes].. PubMed. 57(3). 183–91. 1 indexed citations
13.
Schmidt‐Kastner, Rainald, et al.. (2014). Differential distribution of hypoxia-inducible factor 1-beta (ARNT or ARNT2) in mouse substantia nigra and ventral tegmental area. Journal of Chemical Neuroanatomy. 61-62. 64–71. 11 indexed citations
14.
Vrolix, Kathleen, Judith Fraussen, Mario Losen, et al.. (2014). Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. Journal of Autoimmunity. 52. 101–112. 44 indexed citations
15.
Martínez‐Martínez, Pilar, Peter Molenaar, Mario Losen, et al.. (2013). Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders. Frontiers in Genetics. 4. 181–181. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026